Reading the tape
NYSE: RVTY
Revvity, Inc.
Healthcare · Medical - Diagnostics & Research
Market Cap
$9.67B
52w High
$118.30
52w Low
$81.22
P/E
40.53
Volume
1.57M
Outstanding Shares
111.80M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -6.81%Revenue (TTM): 3.67%FCF (TTM): -5.69%P/FCF: 13th pct
What changed
The stock fell 6.81% over the last year. Revenue grew 3.67% over the trailing twelve months. Operating margin moved from 14.9% to 13.04%. Free cash flow declined 5.69% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 13.04%. A decisive move in revenue — currently up 3.67% — would be the clearest signal to resolve the ambiguity.
Company profile
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide.
CEOPrahlad R. Singh
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees11,000
IPO dateJul 6, 1965
Valuation
Forward P/E—
EV/EBITDA20.51
Enterprise value$13.59B
Stock splits
Jun 4, 2001↑ Forward
Every 1 shares became 2
May 11, 1992↑ Forward
Every 1 shares became 2
Feb 2, 1982↑ Forward
Every 1 shares became 2
Feb 4, 1980↑ Forward
Every 1 shares became 2
Profitability & growth
Revenue growth5.85%
Gross margin50.16%▲10.57%vs FY2024
Operating margin13.04%▼16.20%vs FY2024
ROE3.33%▼13.61%vs FY2024
Analyst consensus
RatingBuy
Target price$111.29▲28.64%
15
Buy
14
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
Q2 FY26 · EPS est $1.02 · Revenue est $704.2M
View
Dividends
$0.28/shareQuarterlyDividend Aristocrat · 34yrSafeRVTY pays a dividend with a 0.32% declared yield, 34 consecutive years of growth, covered 15.5× by free cash flow.
Declared Yield
0.32%
Annual Div / Share
$0.28
5yr CAGR
+0%
Payout Ratio
13.57%
Safe
Dividend Growth Rate
3yr CAGR
+0%
5yr CAGR
+0%
10yr CAGR
+0%
Dividend Safety
10/10Safe
Dividend History
Annualized dividend cycles per share
YearAnnual DivYoY
2026$0.28+0.0%
2025$0.28+0.0%
2024$0.28+0.0%
2023$0.28+0.0%
2022$0.28+0.0%
2021$0.28+0.0%
2020$0.28+0.0%
Income Projection
Invest
$
Growth rate:
Reinvest dividends
Today
$3/yr
$0/mo
In 5 yrs
$3/yr
$0/mo
In 10 yrs
$3/yr
$0/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$3/yr $0/mo | $3/yr $0/mo | $3/yr $0/mo |
Analysis
Dividend Strengths
Dividend Aristocrat
RVTY has raised its dividend for 34 consecutive years — qualifying as a Dividend Aristocrat, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 15.5× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Risks to Watch
No strong risk signal stands out from the latest period pair.